|
Europe Liver disease Articles
Europe Liver disease News : Vertex Nails Third Big Trial With Hepatitis C Drug Tue, 07 Sep 2010 09:51:43 GMT GENETICALLY engineered foods using technologies that have been rejected in Europe and India due to health concerns are to be approved for sale in Australia.Europe Liver disease News : Nsaids May Directly Ease Muscle and Joint Pain Mon, 06 Sep 2010 18:45:15 GMT Controlled trials suggest that a topical nonsteroidal anti-inflammatory drug in a cream is as effective as their oral counterparts for treating osteoarthritis, soreness and tendinitis.Substance abuse, not mental illness, causes violent crime Tue, 07 Sep 2010 19:00:33 GMT Study finds people with drink or drug addictions have similar rates of violent crimes whether or not they have a mental illness Illnesses such as schizophrenia and bipolar disorder are not the reason why violent crimes are committed by mental health patients, a study showed today. An exhaustive study which tracked more than 8,000 patients diagnosed with schizophrenia and another 3,700 identified ...Soprano has cancer, yet active in key of life Tue, 07 Sep 2010 07:36:15 GMT "Now I can stand on my own. I'm actually doing great," Zheng Cao is saying, seated comfortably in her high-rise apartment looking out over the water and the soaring Bay Bridge. Cao, a Shanghai-born mezzo-soprano, beams as she recounts the story of the past... Mezzo-soprano - Soprano - Music - Arts - Vocal65% of People Whose Prior Treatment for Hepatitis C Was Unsuccessful Achieved SVR (Viral Cure) with Telaprevir-Based ... Tue, 07 Sep 2010 20:12:16 GMT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 65% of people overall achieved a sustained viral response (SVR or viral cure) with a telaprevir-based regimen in the pivotal Phase 3 REALIZE study, as compared to 17% of people in the control arm who received pegylated-interferon and ribavirin alone. REALIZE enrolled three groups of ...European Regulators Urged to Pull Avandia Tue, 07 Sep 2010 20:21:39 GMT We recently wrote that emerging research has added to the growing body of evidence linking the diabetes drug Avandia (generic: rosiglitazone) to increased adverse health risks. That issue is cardiac, according to the LA Times. Now, the Wall Street Journal writes that the British Medical Journal just said that Avandia maker GlaxoSmithKline PLC should not [...]65% of People Whose Prior Treatment for Hepatitis C Was Unsuccessful Achieved SVR (Viral Cure) with Telaprevir-Based ... Tue, 07 Sep 2010 20:01:00 GMT CAMBRIDGE, Mass.----Vertex Pharmaceuticals Incorporated today announced that 65% of people overall achieved a sustained viral response with a telaprevir-based regimen in the pivotal Phase 3 REALIZE study, as compared to 17% of people in the control arm who received pegylated-interferon and ribavirin alone.Test your nutrition IQ: Valerian root Tue, 07 Sep 2010 04:56:19 GMT http://www.JewishWorldReview.com | Suffering from insomnia but don't want to take sleeping pills? If you listen to late-night infomercials (and you can't sleep, so you probably do), you've no doubt heard of valerian root touted as a "natural" way to alleviate the problem.Reportlinker Adds Biomarkers - technologies, markets and companies Tue, 07 Sep 2010 14:39:00 GMT Reportlinker.com announces that a new market research report is available in its catalogue:Reportlinker Adds Cardiovascular Drug Delivery - Technologies, Markets and Companies Tue, 07 Sep 2010 14:54:00 GMT NEW YORK , Sept. 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Cardiovascular Drug Delivery - technologies, markets and companies http://www.reportlinker.com/p0203538/Cardiovascular-Drug-Delivery---technologiesmarkets-and-companies.html Summary Drug delivery to the cardiovascular system is different from ...Camel dairy hopes to milk health food market Sun, 05 Sep 2010 12:37:17 GMT The camels know the drill by heart. Just after dawn, they file on their own - always in groups of 12 - into metal stalls for milking. Workers attach automated pumps. The milk flows into a system of chilled pipes that empty into a sealed metal vat. The next... Milk - Dairy - Camel - Business - CattleCamel dairy hopes to milk health food market Sun, 05 Sep 2010 04:06:58 GMT The camels know the drill by heart. Just after dawn, they file on their own - always in groups of 12 - into metal stalls for milking. Workers attach automated pumps. The milk flows into a system of chilled pipes that empty into a sealed metal vat. The next... Milk - Dairy - Business - Camel - FoodMSD Receives European Approval Of Its Atypical Antipsychotic Medication SYCREST(R) For The Treatment Of Manic Episodes ... Sun, 05 Sep 2010 10:11:33 GMT MSD (MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A). announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today's decision was based on recommendations ...New Partnership Forms To Address The Hepatitis B And C Epidemic In Europe Fri, 03 Sep 2010 13:27:01 GMT At least 23 million European Union (EU) citizens are currently living with hepatitis B or hepatitis C,[i] both cancer-causing viruses. In a direct response to the health burden this presents and the recent recognition by the WHO of the seriousness of hepatitis as a global health issue, a unique Partnership comprising key international public and private stakeholders has formed to drive the first ...WHO revises treatment protocols for HIV patients Fri, 03 Sep 2010 12:12:42 GMT Prompted by clinical research into the early initiation of antiretroviral therapies for HIV performed at the GHESKIO clinic in Port-au-Prince, Haiti, the World Health Organization (WHO) has revised its treatment protocols for HIV patients.Pfizer Picking Up FoldRx in Latest Rare Disease Buyout Thu, 02 Sep 2010 01:30:12 GMT Just days after Sanofi-Aventis SA's official bid for Genzyme Corp., big pharma's pursuit of orphan drugs continued with Pfizer Inc.'s plan to buy out privately held FoldRx Pharmaceuticals Inc. for rights to a drug for rare neurodegenerative disease transthyretin amyloid polyneuropathy (ATTR-PN).Abbott gets US FDA nod for Abbott RealTime HBV assay, automated molecular test for assessing hep B treatment Fri, 03 Sep 2010 04:42:31 GMT Abbott has received approval from the US Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.Britain's bottle battle pits prohibition against tradition Fri, 03 Sep 2010 02:00:53 GMT Britain's bottle battle pits prohibition against traditionAbbott Receives FDA Approval For First Automated Molecular Test For Assessing Hepatitis B Treatment Thu, 02 Sep 2010 12:29:36 GMT Abbott (NYSE: ABT) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results. The Abbott RealTime HBV assay, based on ...New Study Links Meridia Diet Pill to Heart Attacks Thu, 02 Sep 2010 19:51:58 GMT Prescription weight loss medication Meridia (sibutramine) has long been linked to cardiac risks. Now, says Reuters, an Abbott Laboratories study provided additional proof that the medication leads to increased heart risks, which has prompted heightened requests to have the drug banned. Preliminary data from the Sibutramine Cardiovascular Morbidity/Mortality Outcomes in Overweight or Obese ...Pfizer to acquire Massachusetts research firm Thu, 02 Sep 2010 06:13:12 GMT Pfizer Inc. announced Wednesday it plans to acquire a Massachusetts research company known for pioneering work on neurogenerative disorders, initially including Huntington's and Parkinson's diseasesMSD Receives European Approval of its Atypical Antipsychotic Medication SYCREST® (asenapine) for the Treatment of ... Thu, 02 Sep 2010 13:18:32 GMT WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD (MSD is a tradename of Merck & Co., Inc., with headquarters in Whitehouse Station, N.J., U.S.A). announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today ...GI Dynamics, Elemental Healthcare sign agreement for distribution of EndoBarrier Gastrointestinal Liner Thu, 02 Sep 2010 09:42:42 GMT GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced it has entered into a new agreement with Elemental Healthcare, based in Hungerford, Berkshire, for the distribution of the EndoBarrier Gastrointestinal Liner in England, Wales, Scotland, Northern Ireland and Ireland.Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment Wed, 01 Sep 2010 18:14:59 GMT DES PLAINES, Ill., Sept. 1 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction ...King's College Hospital Paediatric ICU Goes Live with MetaVision Thu, 02 Sep 2010 09:00:00 GMT LEIDEN, Netherlands----iMDsoft® announces that King's College Hospital has gone live with iMDsoft’s MetaVision® suite in its 16-bed critical care unit .King's College Hospital Paediatric ICU Goes Live with MetaVision Thu, 02 Sep 2010 09:14:59 GMT LEIDEN, Netherlands--(BUSINESS WIRE)--King's College Hospital paediatric ICU goes live with MetaVision. Top London paediatric intensive care unit implements iMDsoft's clinical information system.Longevity = a hereditary factor + lifestyle Wed, 01 Sep 2010 18:06:30 GMT Why do some people live longer than others? The answer may very well consist of a combination of several factors including a complex system of genes and one’s lifestyle.Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment Wed, 01 Sep 2010 14:05:00 GMT Abbott announced today it has received approval from the U.S. Food and Drug Administration to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus in a patient's blood. |
Infectious and parasitic diseases |
|
|
< Home > |
||